BENDEKA (BENDAMUSTINE HCI) INJECTION
UnknownCombined Mark
•
Never miss important updates for BENDEKA (BENDAMUSTINE HCI) INJECTION
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Ownership
TP
Current Owner
Address
West Chester, PA 19380
Critical Dates
First Use Date
Apr 27, 2016
Filing Date
Nov 20, 2015
Registration Date
Aug 2, 2016
Mark Descriptions
Services
Class 44
Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
Mark Elements
Text Mark
BENDEKA (BENDAMUSTINE HCI) INJECTION
Category
Service mark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description
The mark consists of the word "BENDEKA" in capital orange letters with the words "bendamustine HCI" in lower case gray letters directly underneath in parenthesis and the word "injection" in lower case gray letters directly underneath. There is a tilted triangle shape of gray, lime green and orange ribbons directly to the left of the word "BENDEKA".
Color Details
The color(s) orange, lime green and gray is/are claimed as a feature of the mark.
Design Search Codes
09.01.04
Bows, decorative26.05.09
Triangles made of geometric figures, objects, humans, plants or animals26.05.28
Miscellaneous designs with overall triangular shapeRelated Registrations
5014705
4938294
Trademark Timeline
Filing Date
Publication Date
First Use
Registration Date
Trademark Assignment
Assigned to TEVA PHARMACEUTICALS INTERNATIONAL GMBH
USPTO Records
No documents found for this trademark.